Astera Labs Inc (ALAB) concluded trading on Wednesday at a closing price of $99.86, with 5.61 million shares of worth about $560.4 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -29.14% during that period and on July 09, 2025 the price saw a gain of about 8.19%. Currently the company’s common shares owned by public are about 164.91M shares, out of which, 125.71M shares are available for trading.
Stock saw a price change of 12.63% in past 5 days and over the past one month there was a price change of 10.04%. Year-to-date (YTD), ALAB shares are showing a performance of 68.00% which decreased to -24.61% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $36.22 but also hit the highest price of $147.39 during that period. The average intraday trading volume for Astera Labs Inc shares is 4.24 million. The stock is currently trading 8.37% above its 20-day simple moving average (SMA20), while that difference is up 13.90% for SMA50 and it goes to 14.67% higher than SMA200.
Astera Labs Inc (NASDAQ: ALAB) currently have 164.91M outstanding shares and institutions hold larger chunk of about 60.49% of that.
The stock has a current market capitalization of $16.47B and its 3Y-monthly beta is at 1.19. PE ratio of stock for trailing 12 months is 425.66, while it has posted earnings per share of $0.23 in the same period. Its PEG reads 10.21 and has Quick Ratio of 13.26 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALAB, volatility over the week remained 4.87% while standing at 6.24% over the month.
Stock’s fiscal year EPS is expected to rise by 60.69% while it is estimated to increase by 27.78% in next year.
Coverage by Susquehanna stated Astera Labs Inc (ALAB) stock as a Neutral in their note to investors on May 16, 2025, suggesting a price target of $80 for the stock. On May 12, 2025, Morgan Stanley Upgrade their recommendations, while on March 14, 2025, Raymond James Initiated their ratings for the stock with a price target of $82. Stock get an Outperform rating from Northland Capital on January 28, 2025.
